Literature DB >> 8747685

Thromboelastography and cardiopulmonary bypass.

B D Spiess1.   

Abstract

The TEG tracks postoperative hemorrhage after CPB and is useful in guiding therapy. Its ability to characterize the overall interaction of all procoagulant participants in a final outcome (clot strength) is unique. Much work in the future is needed to establish the particular applications for TEG monitoring in CPB patients

Entities:  

Mesh：

Year:  1995        PMID： 8747685

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


  5 in total

1.  Toward a definition of "fresh" whole blood: an in vitro characterization of coagulation properties in refrigerated whole blood for transfusion.

Authors:  David Jobes; Yanika Wolfe; Daniel O'Neill; Jennifer Calder; Lisa Jones; Deborah Sesok-Pizzini; X Long Zheng
Journal:  Transfusion       Date:  2011-01       Impact factor: 3.157

Review 2.  Antithrombotic therapy for the CardioWest temporary total artificial heart.

Authors:  Christopher R Ensor; William D Cahoon; Michael A Crouch; Gundars J Katlaps; Michael L Hess; Richard H Cooke; Kyle J Gunnerson; Vigneshwar Kasirajan
Journal:  Tex Heart Inst J       Date:  2010

Review 3.  Assessment of oral antithrombotic therapy by platelet function testing.

Authors:  Udaya S Tantry; Paul A Gurbel
Journal:  Nat Rev Cardiol       Date:  2011-07-19       Impact factor: 32.419

Review 4.  Surgery in a patient with liver disease.

Authors:  Rakesh Rai; Sanjay Nagral; Aabha Nagral
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

5.  Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time.

Authors:  Myung S Park; Wenjun Z Martini; Michael A Dubick; Jose Salinas; Saulius Butenas; Bijan S Kheirabadi; Anthony E Pusateri; Jeffrey A Vos; Charles H Guymon; Steven E Wolf; Kenneth G Mann; John B Holcomb
Journal:  J Trauma       Date:  2009-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.